Cargando…
A selective review of glutamate pharmacological therapy in obsessive–compulsive and related disorders
Glutamate, an excitatory central nervous system neurotransmitter, is emerging as a potential alternative pharmacological treatment when compared to gamma-aminobutyric acid (GABA)-, dopamine-, and serotonin-modulating treatments for neuropsychiatric conditions. The pathophysiology, animal models, and...
Autores principales: | Grados, Marco A, Atkins, Elizabeth B, Kovacikova, Gabriela I, McVicar, Erin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425334/ https://www.ncbi.nlm.nih.gov/pubmed/25995654 http://dx.doi.org/10.2147/PRBM.S58601 |
Ejemplares similares
-
Could dietary glutamate be contributing to the symptoms of obsessive-compulsive disorder?
por: Holton, Kathleen F, et al.
Publicado: (2018) -
Cortical glutamate and GABA are related to compulsive behaviour in individuals with obsessive compulsive disorder and healthy controls
por: Biria, Marjan, et al.
Publicado: (2023) -
Investigating the Role of Glutamate in Obsessive-Compulsive Disorder: Current Perspectives
por: Karthik, Sheshachala, et al.
Publicado: (2020) -
The Neuronal Glutamate Transporter EAAT3 in Obsessive-Compulsive Disorder
por: Escobar, Angélica P., et al.
Publicado: (2019) -
Perceived Stress in Obsessive–Compulsive Disorder is Related with Obsessive but Not Compulsive Symptoms
por: Morgado, P., et al.
Publicado: (2013)